RT Journal Article
SR Electronic
T1 Electrocardiographic Findings in Psoriatic Arthritis: A Case-Controlled Study
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 2379
OP 2382
DO 10.3899/jrheum.080314
VO 35
IS 12
A1 JOY FELD
A1 GIORA WEISS
A1 ITZHAK ROSNER
A1 MICHAEL ROZENBAUM
A1 ARIE LAOR
A1 DORON RIMAR
A1 LIHI EDER
A1 HAIM BITTERMAN
A1 DEVY ZISMAN
YR 2008
UL http://www.jrheum.org/content/35/12/2379.abstract
AB Objective We assessed cardiac conduction properties in patients with psoriatic arthritis (PsA). Methods Electrocardiogram (ECG) scans of 92 patients with PsA were compared to 92 age and sex matched nonpsoriatic, nonarthritic patients from general practice serving as controls. Results PR interval was found to be significantly longer in the PsA group compared to controls, 159.6 ± 21 ms versus 151.3 ± 26 ms, respectively (p = 0.021). No statistical difference was found with respect to the QRS interval or other atrial or ventricular conduction disturbances studied. No correlation was found between the PR interval and disease duration or PsA subtype. The use of non-steroidal antiinflammatory drugs did not affect the PR interval. Methotrexate was not found to influence the PR interval, compared to other disease modifying antirheumatic drugs. Two PsA patients (2.1%) had a PR interval > 0.2 ms. Their prolonged PR interval could not be explained by medication use. The abnormal prolongation of the PR interval was asymptomatic, requiring no additional intervention. No patient had complete heart block. Conclusion Our study may suggest subtle involvement of the atrioventricular node in patients with PsA.